BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3902023)

  • 1. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
    Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
    Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and inhibition by cytotoxic and antimetastatic drugs of cathepsin B-like cysteine proteinase in transplantable leukemias in mice.
    Giraldi T; Sava G; Zorzet S; Perissin L; Piccini P
    Anticancer Res; 1987; 7(3 Pt B):343-6. PubMed ID: 3307599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Naphthylamidase activity of the cell surface of Ehrlich ascites cells. Reversible control of enzyme activity by metal ions and thiols.
    Short AK; Steven FS; Griffin MM; Itzhaki S
    Br J Cancer; 1981 Nov; 44(5):709-16. PubMed ID: 6797455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK.
    Lassiani L; de Nardo MM; Nisi C; Varnavas A
    Farmaco Sci; 1988 Mar; 43(3):227-38. PubMed ID: 3417008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs.
    Giraldi T; Sava G; Perissin L; Zorzet S; Decorti G; Steven FS
    Invasion Metastasis; 1985; 5(6):336-43. PubMed ID: 3905687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for metal inhibition of tumour membrane-bound neutral protease and the control of tumour-induced target cell cytolysis.
    Steven FS; Hulley TP; Griffin MM; Itzhaki S
    Br J Cancer; 1982 Dec; 46(6):934-9. PubMed ID: 6185130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic activity associated with tumour growth and metastasis. Influence of trypsin inhibitor (soya bean) on Ehrlich ascites tumour growth [proceedings].
    Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1119-20. PubMed ID: 66028
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse.
    Colombo T; Garattini S; Lassiani L; D'Incalci M
    Cancer Treat Rep; 1982 Nov; 66(11):1945-8. PubMed ID: 6754075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
    Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of zinc on tumor transplantability.
    Erkell LJ; Ryd W; Hagmar B
    Invasion Metastasis; 1986; 6(2):112-22. PubMed ID: 3634763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
    Steven FS; Griffin MM; Itzhaki GS; Al-Habib A
    Biochim Biophys Acta; 1981 Aug; 660(2):333-40. PubMed ID: 6269636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G; Giraldi T; Nisi C; Bertoli G
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Br J Cancer; 1980 Nov; 42(5):712-21. PubMed ID: 6257267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
    Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
    Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition kinetics of a trypsin-like neutral proteinase on the surface of Ehrlich ascites-tumour cells.
    Steven FS; Griffin MM; Itzhaki S
    Biochem Soc Trans; 1981 Feb; 9(1):146-7. PubMed ID: 7011870
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
    Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
    Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.